Expression of thrombospondin-1 in conjunctival squamous cell carcinoma is correlated to the Ki67 index and associated with progression-free survival.


Journal

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
ISSN: 1435-702X
Titre abrégé: Graefes Arch Clin Exp Ophthalmol
Pays: Germany
ID NLM: 8205248

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 25 01 2021
accepted: 03 05 2021
revised: 27 04 2021
pubmed: 30 5 2021
medline: 1 10 2021
entrez: 29 5 2021
Statut: ppublish

Résumé

Conjunctival squamous cell carcinoma (SCC) is primarily treated with surgical resection. SCC has various stages, and local recurrence is common. The purpose of this study was to investigate thrombospondin-1 expression and its association with prognosis. In this retrospective study, a gene expression array along with immunohistochemistry were performed for the evaluation of thrombospondin-1 expression, localization, as well as Ki67 labeling cell indices in carcinoma in situ (Tis) and advanced conjunctival SCC (Tadv). The presence or absence and intensity of cytoplasmic and nuclear staining in tumor cells were also divided into groups with a score of 0-3 and semi-quantitatively analyzed to investigate intracellular staining patterns. The association between thrombospondin-1 expression and tumor progression in a series of 31 conjunctival SCCs was further investigated. All 31 patients in the cohort (100%) were East Asian. A simple comparison between Tis and Tadv demonstrated significant differences in expressions of 45 genes, including thrombospondin-1 (p < 0.01). In this cohort, 30/31 tumors were positive (96%) for thrombospondin-1. Furthermore, thrombospondin-1 intracellular staining pattern analysis scores were 2.12 and 0.96 for nuclear and cytoplasmic staining, respectively, with a significant difference observed between Tis and Tadv (p < 0.01). Alteration of the Ki67 labeling index was significantly correlated with that of the thrombospondin-1 cytoplasmic score (p = 0.030). Furthermore, univariate Cox regression analysis showed a significant correlation between thrombospondin-1 staining and progression-free survival (p = 0.026) and final orbital exenteration (p = 0.019). The present results demonstrated that thrombospondin-1 is a potential molecular target in the pathology of conjunctival SCC, in addition to serving as a prognostic factor.

Identifiants

pubmed: 34050808
doi: 10.1007/s00417-021-05236-7
pii: 10.1007/s00417-021-05236-7
doi:

Substances chimiques

Ki-67 Antigen 0
Thrombospondin 1 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3127-3136

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Lee GA, Hirst LW (1995) Ocular surface squamous neoplasia. Surv Ophthalmol 39:429–450. https://doi.org/10.1016/s0039-6257(05)80054-2
doi: 10.1016/s0039-6257(05)80054-2 pubmed: 7660300
Cruzado-Sanchez D, Tellez WA, Villarreal-Aguilar B, Melendez M, Olivera A, Moran F, Serpas-Frias S, Cordero-Garcia R (2020) Conjunctival squamous cell carcinoma: prognostic factors for the recurrence and metastasis and clinicopathological characteristics at an oncological hospital in Peru. Br J Ophthalmol 104:1010–1015. https://doi.org/10.1136/bjophthalmol-2019-314058
doi: 10.1136/bjophthalmol-2019-314058 pubmed: 31604702
Scholz SL, Thomasen H, Reis H, Moller I, Darawsha R, Muller B, Dekowski D, Sucker A, Schilling B, Schadendorf D, Steuhl KP, Paschen A, Westekemper H, Meller D, Griewank KG (2015) Frequent TERT promoter mutations in ocular surface squamous neoplasia. Invest Ophthalmol Vis Sci 56:5854–5861. https://doi.org/10.1167/iovs.15-17469
doi: 10.1167/iovs.15-17469 pubmed: 26348634
Nagarajan P, El-Hadad C, Gruschkus SK, Ning J, Hudgens CW, Sagiv O, Gross N, Tetzlaff MT, Esmaeli B (2019) PD-L1/PD1 Expression, composition of tumor-associated immune infiltrate, and HPV status in conjunctival squamous cell carcinoma. Invest Ophthalmol Vis Sci 60:2388–2398. https://doi.org/10.1167/iovs.19-26894
doi: 10.1167/iovs.19-26894 pubmed: 31141610 pmcid: 6890426
Sakai A, Tagami M, Kakehashi A, Katsuyama-Yoshikawa A, Misawa N, Wanibuchi H, Azumi A, Honda S (2020) Expression, intracellular localization, and mutation of EGFR in conjunctival squamous cell carcinoma and the association with prognosis and treatment. PLoS ONE 15:e0238120. https://doi.org/10.1371/journal.pone.0238120
doi: 10.1371/journal.pone.0238120 pubmed: 32833992 pmcid: 7444806
Lawler JW, Slayter HS, Coligan JE (1978) Isolation and characterization of a high molecular-weight glycoprotein from human-blood platelets. J Biol Chem 253:8609–8616
doi: 10.1016/S0021-9258(17)34336-3
Streit M, Velasco P, Brown LF, Skobe M, Richard L, Riccardi L, Lawler J, Detmar M (1999) Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am J Pathol 155:441–452. https://doi.org/10.1016/s0002-9440(10)65140-1
doi: 10.1016/s0002-9440(10)65140-1 pubmed: 10433937 pmcid: 1866855
Daubon T, Leon C, Clarke K, Andrique L, Salabert L, Darbo E, Pineau R, Guerit S, Maitre M, Dedieu S, Jeanne A, Bailly S, Feige JJ, Miletic H, Rossi M, Bello L, Falciani F, Bjerkvig R, Bikfalvi A (2019) Deciphering the complex role of thrombospondin-1 in glioblastoma development. Nat Commun 10:1146. https://doi.org/10.1038/s41467-019-08480-y
doi: 10.1038/s41467-019-08480-y pubmed: 30850588 pmcid: 6408502
Nucera C, Porrello A, Antonello ZA, Mekel M, Nehs MA, Giordano TJ, Gerald D, Benjamin LE, Priolo C, Puxeddu E, Finn S, Jarzab B, Hodin RA, Pontecorvi A, Nose V, Lawler J, Parangi S (2010) B-Raf<sup>V600E</sup> and thrombospondin-1 promote thyroid cancer progression. Proc Natl Acad Sci 107:10649–10654. https://doi.org/10.1073/pnas.1004934107
doi: 10.1073/pnas.1004934107 pubmed: 20498063 pmcid: 2890809
Sargiannidou I, Zhou J, Tuszynski GP (2001) The role of thrombospondin-1 in tumor progression. Exp Biol Med 226:726–733. https://doi.org/10.1177/153537020222600803
doi: 10.1177/153537020222600803
Sekiyama E, Nakamura T, Cooper LJ, Kawasaki S, Hamuro J, Fullwood NJ, Kinoshita S (2006) Unique distribution of thrombospondin-1 in human ocular surface epithelium. Invest Ophthalmol Vis Sci 47:1352–1358. https://doi.org/10.1167/iovs.05-1305
doi: 10.1167/iovs.05-1305 pubmed: 16565368
Contreras-Ruiz L, Ryan DS, Sia RK, Bower KS, Dartt DA, Masli S (2014) Polymorphism in THBS1 gene is associated with post-refractive surgery chronic ocular surface inflammation. Ophthalmology 121:1389–1397. https://doi.org/10.1016/j.ophtha.2014.01.033
doi: 10.1016/j.ophtha.2014.01.033 pubmed: 24679443
Tisell LE, Oden A, Muth A, Altiparmak G, Molne J, Ahlman H, Nilsson O (2003) The Ki67 index a prognostic marker in medullary thyroid carcinoma. Br J Cancer 89:2093–2097. https://doi.org/10.1038/sj.bjc.6601453
doi: 10.1038/sj.bjc.6601453 pubmed: 14647143 pmcid: 2376863
Cheang MCU, Chia SK, Voduc D, Gao D, Leung S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, Perou CM, Ellis MJ, Nielsen TO (2009) Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 101:736–750. https://doi.org/10.1093/jnci/djp082
doi: 10.1093/jnci/djp082 pubmed: 19436038 pmcid: 2684553
Hall PA, Levison DA, Woods AL, Yu CC, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R et al (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162:285–294. https://doi.org/10.1002/path.1711620403
doi: 10.1002/path.1711620403 pubmed: 1981239
Cesano A (2015) nCounter((R)) PanCancer Immune Profiling Panel (NanoString Technologies Inc, Seattle, WA). J Immunother Cancer 3:42. https://doi.org/10.1186/s40425-015-0088-7
doi: 10.1186/s40425-015-0088-7 pubmed: 26674611 pmcid: 4678588
Posner KL, Sampson PD, Caplan RA, Ward RJ, Cheney FW (1990) Measuring interrater reliability among multiple raters: an example of methods for nominal data. Stat Med 9:1103–1115. https://doi.org/10.1002/sim.4780090917
doi: 10.1002/sim.4780090917 pubmed: 2244082
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174. https://doi.org/10.2307/2529310
doi: 10.2307/2529310 pubmed: 843571 pmcid: 843571
Ohara M, Sotozono C, Tsuchihashi Y, Kinoshita S (2004) Ki-67 labeling index as a marker of malignancy in ocular surface neoplasms. Jpn J Ophthalmol 48:524–529. https://doi.org/10.1007/s10384-004-0129-0
doi: 10.1007/s10384-004-0129-0 pubmed: 15592775
Nuessle S, Soriano D, Boehringer D, Mittelviefhaus H, Lange C, Reinhard T, Atzrodt L, Auw-Haedrich C (2020) HIF-1alpha, HIF-2alpha, and ProExC: diagnostic or prognostic relevance in conjunctival intraepithelial neoplasia? Graefes Arch Clin Exp Ophthalmol 258:2023–2030. https://doi.org/10.1007/s00417-020-04734-4
doi: 10.1007/s00417-020-04734-4 pubmed: 32458097 pmcid: 7438294
Huang TT, Sun L, Yuan XL, Qiu H (2017) Thrombospondin-1 is a multifaceted player in tumor progression. Oncotarget 8:84546–84558. https://doi.org/10.18632/oncotarget.19165
doi: 10.18632/oncotarget.19165 pubmed: 29137447 pmcid: 29137447
Albo D, Rothman VL, Roberts DD, Tuszynski GP (2000) Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor. Br J Cancer 83:298–306. https://doi.org/10.1054/bjoc.2000.1268
doi: 10.1054/bjoc.2000.1268 pubmed: 10917542 pmcid: 2374573
Huang CH, Huang TY, Chang WJ, Pan YS, Chu HR, Li ZL, Unson S, Chin YT, Lin CY, Huang HM, Hsiung CN, Gionfra F, De Vito P, Pedersen JZ, Incerpi S, Chen YR, Lee SY, Lin HY, Davis PJ, Whang-Peng J, Wang K (2020) Combined treatment of heteronemin and tetrac induces antiproliferation in oral cancer cells. Mar Drugs 18: https://doi.org/10.3390/md18070348
Tzeng HT, Tsai CH, Yen YT, Cheng HC, Chen YC, Pu SW, Wang YS, Shan YS, Tseng YL, Su WC, Lai WW, Wu LW, Wang YC (2017) Dysregulation of Rab37-mediated cross-talk between cancer cells and endothelial cells via thrombospondin-1 promotes tumor neovasculature and metastasis. Clin Cancer Res 23:2335–2345. https://doi.org/10.1158/1078-0432.CCR-16-1520
doi: 10.1158/1078-0432.CCR-16-1520 pubmed: 28151721
Moodycliffe AM, Nghiem D, Clydesdale G, Ullrich SE (2000) Immune suppression and skin cancer development: regulation by NKT cells. Nat Immunol 1:521–525. https://doi.org/10.1038/82782
doi: 10.1038/82782 pubmed: 11101875
Kanaya R, Kase S, Ishijima K, Ishida S (2019) Usefulness of topical interferon alpha-2b eye drop as an adjunctive therapy following surgical resection in ocular surface squamous neoplasia. Vivo 33:2211–2215. https://doi.org/10.21873/invivo.11724
doi: 10.21873/invivo.11724
McKelvie PA, Daniell M, McNab A, Loughnan M, Santamaria JD (2002) Squamous cell carcinoma of the conjunctiva: a series of 26 cases. Br J Ophthalmol 86:168–173. https://doi.org/10.1136/bjo.86.2.168
doi: 10.1136/bjo.86.2.168 pubmed: 11815342 pmcid: 1770993
Yip L, Fuhlbrigge R, Atkinson MA, Fathman CG (2017) Impact of blood collection and processing on peripheral blood gene expression profiling in type 1 diabetes. BMC Genomics 18:636. https://doi.org/10.1186/s12864-017-3949-2
doi: 10.1186/s12864-017-3949-2 pubmed: 28821222 pmcid: 5563008
Seiler C, Sharpe A, Barrett JC, Harrington EA, Jones EV, Marshall GB (2016) Nucleic acid extraction from formalin-fixed paraffin-embedded cancer cell line samples: a trade off between quantity and quality? BMC Clin Pathol 16:17. https://doi.org/10.1186/s12907-016-0039-3
doi: 10.1186/s12907-016-0039-3 pubmed: 28649177 pmcid: 5477763

Auteurs

Mizuki Tagami (M)

Department of Ophthalmology and Visual Sciences, Graduate School of Medicine, Osaka City University, 1-5-7 Asahimachi, Abeno-ku, Osaka-shi, Osaka, 545-8585, Japan. tagami.mizuki@med.osaka-cu.ac.jp.
Ophthalmology Department and Eye Center, Kobe Kaisei Hospital, Kobe, Hyogo, Japan. tagami.mizuki@med.osaka-cu.ac.jp.

Anna Kakehashi (A)

Department of Molecular Pathology, Graduate School of Medicine, Osaka City University, Osaka, Japan.

Atsushi Sakai (A)

Department of Ophthalmology and Visual Sciences, Graduate School of Medicine, Osaka City University, 1-5-7 Asahimachi, Abeno-ku, Osaka-shi, Osaka, 545-8585, Japan.

Norihiko Misawa (N)

Department of Ophthalmology and Visual Sciences, Graduate School of Medicine, Osaka City University, 1-5-7 Asahimachi, Abeno-ku, Osaka-shi, Osaka, 545-8585, Japan.

Atsuko Katsuyama-Yoshikawa (A)

Ophthalmology Department and Eye Center, Kobe Kaisei Hospital, Kobe, Hyogo, Japan.

Hideki Wanibuchi (H)

Department of Molecular Pathology, Graduate School of Medicine, Osaka City University, Osaka, Japan.

Atsushi Azumi (A)

Ophthalmology Department and Eye Center, Kobe Kaisei Hospital, Kobe, Hyogo, Japan.

Shigeru Honda (S)

Department of Ophthalmology and Visual Sciences, Graduate School of Medicine, Osaka City University, 1-5-7 Asahimachi, Abeno-ku, Osaka-shi, Osaka, 545-8585, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH